Arrhythmias & electrophysiologyGuideline or statement

2026 AHA/ACC Clinical Performance and Quality Measures for Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Performance Measures

Circ Popul Health OutcomesPublished

  • Clinical performance and quality measures

Recommendations

As issued by the authors

  1. The purpose of the writing committee’s performance measures is meant to ensure that patients with newly diagnosed atrial fibrillation (AF) receive a basic clinical evaluation, with an emphasis on secondary prevention for patients at all stages of AF, documenting stroke risk, and, if indicated, providing appropriate anticoagulation.

  2. AF quality measures cover a variety of topics including measuring and addressing health inequities, optimizing antiarrhythmic or anticoagulant treatment, engaging in shared decision-making for rate- versus rhythm-control strategies, and, in appropriate patients, offering catheter ablation for those with heart failure with reduced ejection fraction.

Original publication

2026 AHA/ACC Clinical Performance and Quality Measures for Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Performance Measures. Circ Popul Health Outcomes. Published 17 August 2026. doi:10.1161/hcq.0000000000000149

Summarised from the published abstract; every number is checked against it